Literature DB >> 32976884

Inflection of Akt/mTOR/STAT-3 cascade in TNF-α induced protein 8 mediated human lung carcinogenesis.

Devivasha Bordoloi1, Kishore Banik2, Rajesh Vikkurthi2, Krishan Kumar Thakur2, Ganesan Padmavathi2, Bethsebie Lalduhsaki Sailo2, Sosmitha Girisa2, Arunachalam Chinnathambi3, Tahani Awad Alahmadi4, Sulaiman Ali Alharbi3, Constanze Buhrmann5, Mehdi Shakibaei5, Ajaikumar B Kunnumakkara6.   

Abstract

Lung cancer is the leading cause of cancer-related death across the globe. Despite the marked advances in detection and therapeutic approaches, management of lung cancer patients remains a major challenge to oncologists which can be mainly attributed to late stage diagnosis, tumor recurrence and chemoresistance. Therefore, to overthrow these limitations, there arises a vital need to develop effective biomarkers for the successful management of this aggressive cancer type. Notably, TNF-alpha induced protein 8 (TIPE), a nuclear factor-kappa B (NF-κB)-inducible, oncogenic molecule and cytoplasmic protein which is involved in the regulation of T lymphocyte-mediated immunity and different processes in tumor cells such as proliferation, cell death and evasion of growth suppressors, might serve as one such biomarker which would facilitate effective management of lung cancer. Expression studies revealed this protein to be significantly upregulated in different lung cancer types, pathological conditions, stages and grades of lung tumor compared to normal human lung tissues. In addition, knockout of TIPE led to the reduced proliferation, survival, invasion and migration of lung cancer cells. Furthermore, TIPE was found to function through modulation of Akt/mTOR/STAT-3 signaling cascade. This is the first report which shows the involvement of TIPE in tobacco induced lung carcinogenesis. It positively regulated nicotine, NNK, NNN, and BaP induced proliferation, survival and migration of lung cancer cells possibly via Akt/STAT-3 signaling. Thus, this protein possesses important role in the pathogenesis of lung tumor and hence it can be targeted for developing newer therapeutic interventions for the clinico-management of lung cancer.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Akt/mTOR; Biomarker; Lung cancer; STAT-3; TIPE; Tobacco

Mesh:

Substances:

Year:  2020        PMID: 32976884     DOI: 10.1016/j.lfs.2020.118475

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

1.  Human tumor necrosis factor alpha-induced protein eight-like 1 exhibited potent anti-tumor effect through modulation of proliferation, survival, migration and invasion of lung cancer cells.

Authors:  Devivasha Bordoloi; Ganesan Padmavathi; Kishore Banik; Khwairakpam Amrita Devi; Choudhary Harsha; Sosmitha Girisa; Constanze Buhrmann; Mehdi Shakibaei; Ajaikumar B Kunnumakkara
Journal:  Mol Cell Biochem       Date:  2021-04-25       Impact factor: 3.396

Review 2.  Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer.

Authors:  Sosmitha Girisa; Sahu Henamayee; Dey Parama; Varsha Rana; Uma Dutta; Ajaikumar B Kunnumakkara
Journal:  Mol Biomed       Date:  2021-07-10

Review 3.  The promising potential of piperlongumine as an emerging therapeutics for cancer.

Authors:  Dey Parama; Varsha Rana; Sosmitha Girisa; Elika Verma; Uzini Devi Daimary; Krishan Kumar Thakur; Aviral Kumar; Ajaikumar B Kunnumakkara
Journal:  Explor Target Antitumor Ther       Date:  2021-08-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.